Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

365 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Haemophilia prophylaxis in young patients--a long-term follow-up.
Löfqvist T, Nilsson IM, Berntorp E, Pettersson H. Löfqvist T, et al. Among authors: berntorp e. J Intern Med. 1997 May;241(5):395-400. doi: 10.1046/j.1365-2796.1997.130135000.x. J Intern Med. 1997. PMID: 9183307
Human plasma von Willebrand factor/factor VIII complex (Haemate P/Humate-P) in von Willebrand disease and haemophilia A: a viewpoint by Eric Berntorp.
Berntorp E. Berntorp E. Drugs. 2007;67(10):1520. doi: 10.2165/00003495-200767100-00010. Drugs. 2007. PMID: 17600396 No abstract available.
[Hemophiliacs with HIV. Slower progression of the infection among younger patients and at higher dosages of factor concentrates].
Astermark J, Berntorp E, Stigendal L, Johnsson H. Astermark J, et al. Among authors: berntorp e. Lakartidningen. 1998 Jan 7;95(1-2):48-50. Lakartidningen. 1998. PMID: 9458646 Swedish.
[Centralized care is the basis of care programs for hemophilia patients].
Berntorp E, Lethagen S, Ljung R, Johnsson H, Petrini P, Schulman S, Tengborn L, Rehnby B, Sarman E, Asberg B. Berntorp E, et al. Lakartidningen. 1999 Apr 14;96(15):1849-52. Lakartidningen. 1999. PMID: 10319652 Swedish.
Methods of haemophilia care delivery: regular prophylaxis versus episodic treatment.
Berntorp E. Berntorp E. Haemophilia. 1995 Jan;1 Suppl 1:3-7. doi: 10.1111/j.1365-2516.1995.tb00103.x. Haemophilia. 1995. PMID: 27214733 No abstract available.
Variation in factor VIII inhibitor reactivity with different commercial factor VIII preparations.
Berntorp E, Ekman M, Gunnarsson M, Nilsson IM. Berntorp E, et al. Haemophilia. 1996 Apr;2(2):95-9. doi: 10.1111/j.1365-2516.1996.tb00022.x. Haemophilia. 1996. PMID: 27214015
Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia.
Björkman S, Berntorp E. Björkman S, et al. Among authors: berntorp e. Clin Pharmacokinet. 2001;40(11):815-32. doi: 10.2165/00003088-200140110-00003. Clin Pharmacokinet. 2001. PMID: 11735604 Review.
Clinical spectrum of hepatitis C-related liver disease and response to treatment with interferon and ribavirin in haemophilia or von Willebrand disease.
Lethagen S, Widell A, Berntorp E, Verbaan H, Lindgren S. Lethagen S, et al. Among authors: berntorp e. Br J Haematol. 2001 Apr;113(1):87-93. doi: 10.1046/j.1365-2141.2001.02700.x. Br J Haematol. 2001. PMID: 11328286
Immune tolerance induction and the treatment of hemophilia. Malmö protocol update.
Berntorp E, Astermark J, Carlborg E. Berntorp E, et al. Haematologica. 2000 Oct;85(10 Suppl):48-50; discussion 50-1. Haematologica. 2000. PMID: 11187871
Recombinant FVIIa in the treatment of warfarin bleeding.
Berntorp E. Berntorp E. Semin Thromb Hemost. 2000;26(4):433-5. doi: 10.1055/s-2000-8464. Semin Thromb Hemost. 2000. PMID: 11092220 Review.
365 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback